izpis_h1_title_alt

Low virus-specific IgG antibodies in adverse clinical course and outcome of tick-borne encephalitis
ID Bogovič, Petra (Author), ID Lotrič-Furlan, Stanka (Author), ID Avšič-Županc, Tatjana (Author), ID Korva, Miša (Author), ID Lusa, Lara (Author), ID Strle, Klemen (Author), ID Strle, Franc (Author)

.pdfPDF - Presentation file, Download (1,02 MB)
MD5: AE14D21037EFA54A283A3AB663E45037
URLURL - Source URL, Visit https://www.mdpi.com/2076-2607/9/2/332 This link opens in a new window

Abstract
Tick-borne encephalitis (TBE) is associated with a range of disease severity. The reasons for this heterogeneity are not clear. Levels of serum IgG antibodies to TBE virus (TBEV) were determined in 691 adult patients during the meningoencephalitic phase of TBE and correlated with detailed clinical and laboratory parameters during acute illness and with the presence of post-encephalitic syndrome (PES) 2–7 years after TBE. Specific IgG antibody levels ranged from below cut-off value (in 32/691 patients, 4.6%), to 896 U/mL (median = 37.3 U/mL). Patients with meningoencephalomyelitis were more often seronegative (24.3%; 9/37) than those with meningoencephalitis (4.7%; 20/428) or meningitis (1.3%; 3/226). Moreover, patients with antibody levels below cut-off had longer hospitalization (13 versus 8 days); more often required intensive care unit treatment (22% versus 8%) and artificial ventilation (71% versus 21%); and had a higher fatality rate (3/32; 9.4% versus 1/659; 0.2%) than seropositive patients. These results were confirmed when antibody levels, rather than cut-off values, were correlated with clinical parameters including the likelihood to develop PES. Low serum IgG antibody responses against TBEV at the onset of neurologic involvement are associated with a more difficult clinical course and unfavorable long-term outcome of TBE, providing a diagnostic and clinical challenge for physicians.

Language:English
Keywords:tick-borne encephalitis, humoral immune response, serum IgG antibodies, course, outcome
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:12 str.
Numbering:Vol. 9, iss. 2, art. 332
PID:20.500.12556/RUL-135014 This link opens in a new window
UDC:616.9
ISSN on article:2076-2607
DOI:10.3390/microorganisms9020332 This link opens in a new window
COBISS.SI-ID:51124995 This link opens in a new window
Publication date in RUL:17.02.2022
Views:705
Downloads:126
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Microorganisms
Shortened title:Microorganisms
Publisher:MDPI AG
ISSN:2076-2607
COBISS.SI-ID:523277081 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:07.02.2021

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0296
Name:Bolezni in povzročitelji, ki jih v Sloveniji prenašajo členonožci

Funder:ARRS - Slovenian Research Agency
Project number:J3-1744
Name:Poglobljena analiza vplivov dejavnikov povzročitelja in gostitelja pri akutni in kronični lymski boreliozi

Funder:ARRS - Slovenian Research Agency
Project number:J3-8195
Name:Dejavniki povzročitelja in gostitelja, ki vplivajo na klinične znake, težo in izid lymske borelioze

Funder:Other - Other funder or multiple funders
Funding programme:Global Lyme Alliance

Funder:Other - Other funder or multiple funders
Funding programme:MGH-ECOR

Funder:NIH - National Institutes of Health
Project number:R21 AI144916

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back